Increasing Number of Clinical Trials is a Key Trend Gaining Market Momentum
1h Free Analyst Time
The regenerative medicine market in Japan is forecasted to grow by USD 4.60 billion during 2024-2029, accelerating at a CAGR of 21.2% during the forecast period. The report on the regenerative medicine market in Japan provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing adoption of STEM cell therapy, rising prevalence of chronic diseases, and increasing aging population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The regenerative medicine market in Japan is segmented as below:
By Application
- Oncology
- Musculoskeletal
- Dermatology
- Others
By Technology
- Cell and tissue-based
- Gene therapy
By End-user
- Hospitals and clinics
- Speciality centers
- Government and research institutes
By Geographical Landscape
- APAC
The report on the regenerative medicine market in Japan covers the following areas:
- Regenerative Medicine Market in Japan sizing
- Regenerative Medicine Market in Japan forecast
- Regenerative Medicine Market in Japan industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Application
9 Market Segmentation by Technology
10 Market Segmentation by End-user
11 Customer Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the regenerative medicine market in japan: Astellas Pharma Inc., Becton Dickinson and Co., CellSeed Inc., Cellusion Inc., Cyfuse Biomedical K.K., F. Hoffmann La Roche Ltd., FUJIFILM Holdings Corp., iHeart Japan Corp., Japan Tissue Engineering Co. Ltd., JCR Pharmaceticals Co. Ltd., Nikon Corp., ROHTO Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd., Takara Bio Inc., Takeda Pharmaceutical Co. Ltd., Terumo Corp., and Yokogawa Electric Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing number of clinical trials."
According to the report, one of the major drivers for this market is the increasing adoption of stem cell therapy.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Astellas Pharma Inc.
- Becton Dickinson and Co.
- CellSeed Inc.
- Cellusion Inc.
- Cyfuse Biomedical K.K.
- F. Hoffmann La Roche Ltd.
- FUJIFILM Holdings Corp.
- iHeart Japan Corp.
- Japan Tissue Engineering Co. Ltd.
- JCR Pharmaceticals Co. Ltd.
- Nikon Corp.
- ROHTO Pharmaceutical Co. Ltd.
- Sumitomo Pharma Co. Ltd.
- Takara Bio Inc.
- Takeda Pharmaceutical Co. Ltd.
- Terumo Corp.
- Yokogawa Electric Corp.
